Travere Therapeutics
Price & Volume
Stats
See moreOpen | $20.45 |
Previous Close | $20.37 |
Day Range | $19.67-$20.46 |
52W Range | $5.12-$25.29 |
Market Cap | $1.8B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $233.1M |
Revenue Growth (YoY) | 66% |
Gross Profit (12 Mos) | $7.9M |
Diluted EPS | -$3.99 |
News
See moreYahoo Finance • 11 days ago
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
Yahoo Finance • 16 days ago
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Travere Therapeutics to Participate at Upcoming Investor Conferences
Yahoo Finance • last month
Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 385 |
